|
|
| Discussions for Eli Lilly & Co. |
|
| Buy stxs before breakout approval 25.03.2013 buy and make money
rab...@hotmail.com - |
| URBN running out of steam. Buy at the pull back around $31 range. VXX is going up and can go up 100% as uncertainity and fear grows!!
ztari...@gmail.com - |
| cramer: EPD and KMP front of PVX they are chicken
Cramer: Provident Energy Trust (PVX), Kinder Morgan Energy Partners (KMP), Enterprise Products Partners (EPD): "This is my kind of company (Provident)...it's got a nice yield. Is it as high quality as Kinder Morgan? No. Is it as high quality as EPD? No, but it's a plain good one. [link]... combination8...@yahoo.com - |
| FDA > EMA: New drug approvals
FDA > EMA: New drug approvals The FDA approved 11 NME and EMA 7 in the first 4 months of 2011 and issued 14 complete response letters. Industry R&D had 10 Phase III trials success balanced by 11 phase III failures. Forest and GSK each had 2 new drugs approved. FDA approvals include 5 potential blockbuster brands out of which 2 were ground breaking monoclonal... KM - |
| Here's what I used to conquer LLY
This is the site I told my frield about that uses an investment quiz to qualify you for the hack the market strategy, I've been using on LLY. A pain in the butt to sign up for, a joy to use. [link] Groover Armor - |
| The Secret to Finding a Breakout Stock
You can get the latest news,updates and big market movers at pennystockresearch.net, You are a small step away from Making a Killing in the Stock Market subscribing to their newsletter. Kelly Brooks - |
| UV Flu Technologies (OTC BB: UVFT) poised to go on huge bull run!!
UV Flu Technologies (OTC BB: UVFT) flagship product has full FDA approval as a medical device, and kills bacteria like the NDM-1 Superbug at a 99.2% rate! Get in before the stock goes on a huge bull run this flu season! The stock price is severely undervalued at these levels. The biotech sector is on fire, up 11% in the last month, led... Leo corvalier - |
| APCVZ ==== BUY
BUYYYYYYYYYYYYYYYYYYYYYY masonbro33 - |
| Eli lily v/s ILNS........on Alzheimer...
Intellect Neurosciences' search for Alzheimer's treatment continues without doubts Aug. 20, 2010 (Baystreet.ca) -- The commentary below was submitten by Dr. Daniel Chain, Chief Executive Officer of Intellect Neurosciences after BioMedReports reached out for his thoughts and comments. This after Lilly (NYSE:... DINPAT2003@GMAIL.COM - |
| BRAF Inhibitors in Melanoma
IPI + BRAF inhibitors LLY licensing of the Deciphera BRAF inhibitors 2 years ago was a great move and may result in future blockbusters. The planned Ipilimumab+ PLX 4032 combination trial may roll back metastatic melanoma and may provide an opportunity for LLY braf products. Offers the best hope for cure of MM in combination with biomarkers.... KM - |
| Discussions 1 - 10 of 62 Older » | |
| XML |
| Google Home - Terms of Service - Privacy Policy |
©2013 Google